Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Spiropiperidines for use as tryptase inhibitors

Spiropiperidines for use as tryptase inhibitors

US Patent 8158792 · Granted Apr 17, 2012

Estimated economic value: $41,469,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(12025
Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making2024
Substituted 2-anilinopyrimidine derivatives as EGFR modulators2022
2H-indazole derivatives as CDK4 and CDK6 inhibitors and therapeutic uses thereof2022
Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making2022
Substituted ureas and methods of making and using same2021
Pharmaceutical formulations of N-(2-(2-(dimethylamino) ethoxy)-4-methoxy-5-((4-(2021
2-anilinopyrimidine derivatives as therapeutic agents for treatment of brain can2021
Pharmaceutical salts N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H2020
Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making2020